Global Specialty Drug Distribution

Specialty Drug Distribution Comprehensive Study by Application (Retail, Home Health, Clinics, Pharmacies), Drug Type (Oncology Drugs, Rheumatoid Arthritis Drugs, Multiple Sclerosis Drugs, Hemophilia Drugs), Distribution Channel (Online Channel, Offline Channel) Players and Region - Global Market Outlook to 2030

Specialty Drug Distribution Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Specialty Drug Distribution
Specialty drugs are high-cost prescription medications used to treat complex, chronic conditions like cancer, rheumatoid arthritis, and multiple sclerosis. These drugs sometimes require special handling and administration (typically injection or infusion). They typically require special handling, administration or monitoring. Specialty drug distributors ensure delivery of drugs to hospitals, physician practices, specialty pharmacies and medical clinics accurately.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Specialty Drug Distribution market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Amerisource (United States), McKesson Corporation (United States), Cardinal Health, Inc. (United States), Mediceo Paltac Holdings Co., Ltd. (Japan), Alliance Healthcare (Turkey), Sinopharm Group Co., Ltd. (China), Accredo (United States), Shanghai Pharma (China), Jointown Pharmaceutical (China) and Avella Specialty Pharmacy (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Specialty Drug Distribution market by , Application (Retail, Home Health, Clinics and Pharmacies) and Region.



On the basis of geography, the market of Specialty Drug Distribution has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Drug Type, the sub-segment i.e. Oncology Drugs will boost the Specialty Drug Distribution market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Online Channel will boost the Specialty Drug Distribution market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increased Number of Online Customers and Increased Use of Specialty Drugs to Treat Chronic Diseases

Market Growth Drivers:
Increased Demand for Specialty Drugs and Robust Increase in the Distribution Channels

Challenges:
Stringent Government Rules and Regulations

Restraints:
The Restriction Associated with Distribution Channels

Opportunities:
Growth in the Healthcare Industry Worldwide and Improving Healthcare Infrasture in Developing Countries

Market Leaders and their expansionary development strategies
In April 2021, Amneal Pharmaceuticals, Inc. and Kashiv BioSciences LLC announced that Amneal Pharmaceuticals LLC (“Amneal”), a subsidiary of the Company, has completed its previously announced acquisition of a 98% interest in Kashiv Specialty Pharmaceuticals, LLC (“Kashiv Specialty”), a wholly-owned subsidiary of Kashiv focused on the development of complex generics, innovative drug delivery platforms and novel 505(b)(2) drugs.
In August 2022, House Rx, the platform for medically integrated dispensing of specialty medications, announced it has partnered with three new rheumatology clinics to integrate in-house specialty drug dispensing – also known as medically integrated dispensing (MID) – into the clinics' operations


Key Target Audience
Specialty Drug Distributors, Emerging Companies, Research Professionals and End-users

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Retail
  • Home Health
  • Clinics
  • Pharmacies
By Drug Type
  • Oncology Drugs
  • Rheumatoid Arthritis Drugs
  • Multiple Sclerosis Drugs
  • Hemophilia Drugs

By Distribution Channel
  • Online Channel
  • Offline Channel

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Demand for Specialty Drugs
      • 3.2.2. Robust Increase in the Distribution Channels
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. Increased Number of Online Customers
      • 3.4.2. Increased Use of Specialty Drugs to Treat Chronic Diseases
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Specialty Drug Distribution, by Application, Drug Type, Distribution Channel and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Specialty Drug Distribution (Value)
      • 5.2.1. Global Specialty Drug Distribution by: Application (Value)
        • 5.2.1.1. Retail
        • 5.2.1.2. Home Health
        • 5.2.1.3. Clinics
        • 5.2.1.4. Pharmacies
      • 5.2.2. Global Specialty Drug Distribution by: Drug Type (Value)
        • 5.2.2.1. Oncology Drugs
        • 5.2.2.2. Rheumatoid Arthritis Drugs
        • 5.2.2.3. Multiple Sclerosis Drugs
        • 5.2.2.4. Hemophilia Drugs
      • 5.2.3. Global Specialty Drug Distribution by: Distribution Channel (Value)
        • 5.2.3.1. Online Channel
        • 5.2.3.2. Offline Channel
      • 5.2.4. Global Specialty Drug Distribution Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Specialty Drug Distribution: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Amerisource (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. McKesson Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cardinal Health, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Mediceo Paltac Holdings Co., Ltd. (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Alliance Healthcare (Turkey)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sinopharm Group Co., Ltd. (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Accredo (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Shanghai Pharma (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Jointown Pharmaceutical (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Avella Specialty Pharmacy (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Specialty Drug Distribution Sale, by Application, Drug Type, Distribution Channel and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Specialty Drug Distribution (Value)
      • 7.2.1. Global Specialty Drug Distribution by: Application (Value)
        • 7.2.1.1. Retail
        • 7.2.1.2. Home Health
        • 7.2.1.3. Clinics
        • 7.2.1.4. Pharmacies
      • 7.2.2. Global Specialty Drug Distribution by: Drug Type (Value)
        • 7.2.2.1. Oncology Drugs
        • 7.2.2.2. Rheumatoid Arthritis Drugs
        • 7.2.2.3. Multiple Sclerosis Drugs
        • 7.2.2.4. Hemophilia Drugs
      • 7.2.3. Global Specialty Drug Distribution by: Distribution Channel (Value)
        • 7.2.3.1. Online Channel
        • 7.2.3.2. Offline Channel
      • 7.2.4. Global Specialty Drug Distribution Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Specialty Drug Distribution: by Application(USD Million)
  • Table 2. Specialty Drug Distribution Retail , by Region USD Million (2018-2023)
  • Table 3. Specialty Drug Distribution Home Health , by Region USD Million (2018-2023)
  • Table 4. Specialty Drug Distribution Clinics , by Region USD Million (2018-2023)
  • Table 5. Specialty Drug Distribution Pharmacies , by Region USD Million (2018-2023)
  • Table 6. Specialty Drug Distribution: by Drug Type(USD Million)
  • Table 7. Specialty Drug Distribution Oncology Drugs , by Region USD Million (2018-2023)
  • Table 8. Specialty Drug Distribution Rheumatoid Arthritis Drugs , by Region USD Million (2018-2023)
  • Table 9. Specialty Drug Distribution Multiple Sclerosis Drugs , by Region USD Million (2018-2023)
  • Table 10. Specialty Drug Distribution Hemophilia Drugs , by Region USD Million (2018-2023)
  • Table 11. Specialty Drug Distribution: by Distribution Channel(USD Million)
  • Table 12. Specialty Drug Distribution Online Channel , by Region USD Million (2018-2023)
  • Table 13. Specialty Drug Distribution Offline Channel , by Region USD Million (2018-2023)
  • Table 14. South America Specialty Drug Distribution, by Country USD Million (2018-2023)
  • Table 15. South America Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 16. South America Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 17. South America Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 18. Brazil Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 19. Brazil Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 20. Brazil Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 21. Argentina Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 22. Argentina Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 23. Argentina Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 24. Rest of South America Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 25. Rest of South America Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 26. Rest of South America Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 27. Asia Pacific Specialty Drug Distribution, by Country USD Million (2018-2023)
  • Table 28. Asia Pacific Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 29. Asia Pacific Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 30. Asia Pacific Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 31. China Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 32. China Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 33. China Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 34. Japan Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 35. Japan Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 36. Japan Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 37. India Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 38. India Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 39. India Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 40. South Korea Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 41. South Korea Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 42. South Korea Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 43. Taiwan Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 44. Taiwan Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 45. Taiwan Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 46. Australia Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 47. Australia Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 48. Australia Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 52. Europe Specialty Drug Distribution, by Country USD Million (2018-2023)
  • Table 53. Europe Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 54. Europe Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 55. Europe Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 56. Germany Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 57. Germany Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 58. Germany Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 59. France Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 60. France Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 61. France Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 62. Italy Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 63. Italy Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 64. Italy Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 65. United Kingdom Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 66. United Kingdom Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 67. United Kingdom Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 68. Netherlands Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 69. Netherlands Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 70. Netherlands Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 71. Rest of Europe Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 72. Rest of Europe Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 73. Rest of Europe Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 74. MEA Specialty Drug Distribution, by Country USD Million (2018-2023)
  • Table 75. MEA Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 76. MEA Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 77. MEA Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 78. Middle East Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 79. Middle East Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 80. Middle East Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 81. Africa Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 82. Africa Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 83. Africa Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 84. North America Specialty Drug Distribution, by Country USD Million (2018-2023)
  • Table 85. North America Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 86. North America Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 87. North America Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 88. United States Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 89. United States Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 90. United States Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 91. Canada Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 92. Canada Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 93. Canada Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 94. Mexico Specialty Drug Distribution, by Application USD Million (2018-2023)
  • Table 95. Mexico Specialty Drug Distribution, by Drug Type USD Million (2018-2023)
  • Table 96. Mexico Specialty Drug Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Specialty Drug Distribution: by Application(USD Million)
  • Table 108. Specialty Drug Distribution Retail , by Region USD Million (2025-2030)
  • Table 109. Specialty Drug Distribution Home Health , by Region USD Million (2025-2030)
  • Table 110. Specialty Drug Distribution Clinics , by Region USD Million (2025-2030)
  • Table 111. Specialty Drug Distribution Pharmacies , by Region USD Million (2025-2030)
  • Table 112. Specialty Drug Distribution: by Drug Type(USD Million)
  • Table 113. Specialty Drug Distribution Oncology Drugs , by Region USD Million (2025-2030)
  • Table 114. Specialty Drug Distribution Rheumatoid Arthritis Drugs , by Region USD Million (2025-2030)
  • Table 115. Specialty Drug Distribution Multiple Sclerosis Drugs , by Region USD Million (2025-2030)
  • Table 116. Specialty Drug Distribution Hemophilia Drugs , by Region USD Million (2025-2030)
  • Table 117. Specialty Drug Distribution: by Distribution Channel(USD Million)
  • Table 118. Specialty Drug Distribution Online Channel , by Region USD Million (2025-2030)
  • Table 119. Specialty Drug Distribution Offline Channel , by Region USD Million (2025-2030)
  • Table 120. South America Specialty Drug Distribution, by Country USD Million (2025-2030)
  • Table 121. South America Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 122. South America Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 123. South America Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 124. Brazil Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 125. Brazil Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 126. Brazil Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 127. Argentina Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 128. Argentina Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 129. Argentina Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 130. Rest of South America Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 131. Rest of South America Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 132. Rest of South America Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 133. Asia Pacific Specialty Drug Distribution, by Country USD Million (2025-2030)
  • Table 134. Asia Pacific Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 135. Asia Pacific Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 136. Asia Pacific Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 137. China Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 138. China Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 139. China Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 140. Japan Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 141. Japan Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 142. Japan Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 143. India Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 144. India Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 145. India Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 146. South Korea Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 147. South Korea Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 148. South Korea Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 149. Taiwan Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 150. Taiwan Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 151. Taiwan Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 152. Australia Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 153. Australia Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 154. Australia Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 155. Rest of Asia-Pacific Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 156. Rest of Asia-Pacific Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 157. Rest of Asia-Pacific Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 158. Europe Specialty Drug Distribution, by Country USD Million (2025-2030)
  • Table 159. Europe Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 160. Europe Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 161. Europe Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 162. Germany Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 163. Germany Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 164. Germany Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 165. France Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 166. France Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 167. France Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 168. Italy Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 169. Italy Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 170. Italy Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 171. United Kingdom Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 172. United Kingdom Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 173. United Kingdom Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 174. Netherlands Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 175. Netherlands Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 176. Netherlands Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 177. Rest of Europe Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 178. Rest of Europe Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 179. Rest of Europe Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 180. MEA Specialty Drug Distribution, by Country USD Million (2025-2030)
  • Table 181. MEA Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 182. MEA Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 183. MEA Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 184. Middle East Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 185. Middle East Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 186. Middle East Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 187. Africa Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 188. Africa Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 189. Africa Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 190. North America Specialty Drug Distribution, by Country USD Million (2025-2030)
  • Table 191. North America Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 192. North America Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 193. North America Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 194. United States Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 195. United States Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 196. United States Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 197. Canada Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 198. Canada Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 199. Canada Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 200. Mexico Specialty Drug Distribution, by Application USD Million (2025-2030)
  • Table 201. Mexico Specialty Drug Distribution, by Drug Type USD Million (2025-2030)
  • Table 202. Mexico Specialty Drug Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 203. Research Programs/Design for This Report
  • Table 204. Key Data Information from Secondary Sources
  • Table 205. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Specialty Drug Distribution: by Application USD Million (2018-2023)
  • Figure 5. Global Specialty Drug Distribution: by Drug Type USD Million (2018-2023)
  • Figure 6. Global Specialty Drug Distribution: by Distribution Channel USD Million (2018-2023)
  • Figure 7. South America Specialty Drug Distribution Share (%), by Country
  • Figure 8. Asia Pacific Specialty Drug Distribution Share (%), by Country
  • Figure 9. Europe Specialty Drug Distribution Share (%), by Country
  • Figure 10. MEA Specialty Drug Distribution Share (%), by Country
  • Figure 11. North America Specialty Drug Distribution Share (%), by Country
  • Figure 12. Global Specialty Drug Distribution share by Players 2023 (%)
  • Figure 13. Global Specialty Drug Distribution share by Players (Top 3) 2023(%)
  • Figure 14. Global Specialty Drug Distribution share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Amerisource (United States) Revenue, Net Income and Gross profit
  • Figure 17. Amerisource (United States) Revenue: by Geography 2023
  • Figure 18. McKesson Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 19. McKesson Corporation (United States) Revenue: by Geography 2023
  • Figure 20. Cardinal Health, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Cardinal Health, Inc. (United States) Revenue: by Geography 2023
  • Figure 22. Mediceo Paltac Holdings Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 23. Mediceo Paltac Holdings Co., Ltd. (Japan) Revenue: by Geography 2023
  • Figure 24. Alliance Healthcare (Turkey) Revenue, Net Income and Gross profit
  • Figure 25. Alliance Healthcare (Turkey) Revenue: by Geography 2023
  • Figure 26. Sinopharm Group Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 27. Sinopharm Group Co., Ltd. (China) Revenue: by Geography 2023
  • Figure 28. Accredo (United States) Revenue, Net Income and Gross profit
  • Figure 29. Accredo (United States) Revenue: by Geography 2023
  • Figure 30. Shanghai Pharma (China) Revenue, Net Income and Gross profit
  • Figure 31. Shanghai Pharma (China) Revenue: by Geography 2023
  • Figure 32. Jointown Pharmaceutical (China) Revenue, Net Income and Gross profit
  • Figure 33. Jointown Pharmaceutical (China) Revenue: by Geography 2023
  • Figure 34. Avella Specialty Pharmacy (United States) Revenue, Net Income and Gross profit
  • Figure 35. Avella Specialty Pharmacy (United States) Revenue: by Geography 2023
  • Figure 36. Global Specialty Drug Distribution: by Application USD Million (2025-2030)
  • Figure 37. Global Specialty Drug Distribution: by Drug Type USD Million (2025-2030)
  • Figure 38. Global Specialty Drug Distribution: by Distribution Channel USD Million (2025-2030)
  • Figure 39. South America Specialty Drug Distribution Share (%), by Country
  • Figure 40. Asia Pacific Specialty Drug Distribution Share (%), by Country
  • Figure 41. Europe Specialty Drug Distribution Share (%), by Country
  • Figure 42. MEA Specialty Drug Distribution Share (%), by Country
  • Figure 43. North America Specialty Drug Distribution Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Amerisource (United States)
  • McKesson Corporation (United States)
  • Cardinal Health, Inc. (United States)
  • Mediceo Paltac Holdings Co., Ltd. (Japan)
  • Alliance Healthcare (Turkey)
  • Sinopharm Group Co., Ltd. (China)
  • Accredo (United States)
  • Shanghai Pharma (China)
  • Jointown Pharmaceutical (China)
  • Avella Specialty Pharmacy (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 229 Pages 51 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Specialty Drug Distribution Quantitative research analysis
Global Specialty Drug Distribution Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Amerisource (United States), McKesson Corporation (United States), Cardinal Health, Inc. (United States), Mediceo Paltac Holdings Co., Ltd. (Japan), Alliance Healthcare (Turkey), Sinopharm Group Co., Ltd. (China), Accredo (United States), Shanghai Pharma (China), Jointown Pharmaceutical (China) and Avella Specialty Pharmacy (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increased Number of Online Customers " is seen as one of major influencing trends for Specialty Drug Distribution Market during projected period 2023-2030.
The Specialty Drug Distribution market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Specialty Drug Distribution Report?

Have a Query? Click Here

Other Related Reports

Mulberry Leaf Extract Comprehensive Study by Type (Antioxidants, Dietary Fiber, Organic Compounds, Other), Application (Dietary Supplements, Pharmaceuticals, Cosmetics, Food Industries), Extraction (...
$ 3750
Cancer Drugs Comprehensive Study by Type (Blood Cancer, Breast Cancer, Lung Cancer, Gastrointestinal Cancer, Skin Cancer, Prostate Cancer, Others), Therapy (Immunotherapy, Chemotherapy, Hormone Thera...
$ 3750
Healthcare CMO Comprehensive Study by Type (Pharmaceutical CMOS, Medical Device CMOS, Final Goods Assembly), Application (Medical, Healthcare, Others), Medical Device Services (Outsourcing Design, De...
$ 3750
Protein Biochips Comprehensive Study by Type (Analytic Protein Biochips, Functional Protein Biochips, Reverse Phase Protein Biochips), Application (Diagnostics, Proteomics, Protein functional Analysi...
$ 3750
Anti-depressant Drugs Comprehensive Study by Type (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Sero...
$ 3750
Nutraceutical Ingredients Comprehensive Study by Type (Prebiotics, Probiotics, Minerals, Vitamins, Omega-3 fatty acids, Fibers & specialty carbohydrates, Proteins & amino acids, Carotenoids, Phytoche...
$ 3750